The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical relevance of clonal hematopoiesis in metastatic gastrointestinal malignancies.
 
Bill Diplas
Stock and Other Ownership Interests - crispr therapeutics; Moderna Therapeutics
Patents, Royalties, Other Intellectual Property - Genetron Health; US20170247765A1, EP3186399A4, JP6438119B2, AU2015306907C9 - Methods for rapid and sensitive detection of hotspot mutations; US20210002702A1 - Directing Treatments For Glioblastoma
 
Ryan Ptashkin
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Array Biopharma; Bayer; Proteus Digital Health
Research Funding - Abbvie; Rgenix (Inst); Seagen; Tesaro
 
Rona Yaeger
Consulting or Advisory Role - Array BioPharma; Natera
Research Funding - Array BioPharma (Inst); Boehringer Ingelheim (Inst); Pfizer; Pfizer (Inst)
 
Kelly L Bolton
Research Funding - GRAIL
 
Sree Bhavani Chalasani
No Relationships to Disclose
 
Avni Mukund Desai
No Relationships to Disclose
 
Zoe Goldberg
No Relationships to Disclose
 
Ping Gu
No Relationships to Disclose
 
Jia Li
No Relationships to Disclose
 
Marina Shcherba
No Relationships to Disclose
 
Alice Zervoudakis
No Relationships to Disclose
 
Shalom Sabwa
No Relationships to Disclose
 
Ahmet Zehir
Stock and Other Ownership Interests - Arcus Biosciences; Mirati Therapeutics
Honoraria - Illumina
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Rgenix
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Imugene; Jounce Therapeutics; Lilly; Merck; Merck Serono; Merck Sharpe and Dohme Corp.; Michael J. Hennessy Associates; Ono Pharmaceutical; Pfizer; Rgenix; Seagen; Zymeworks
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Merck; Rgenix (Inst); Roche
Other Relationship - Axis Medical Education; Clinical Care Options; Paradigm; Research to Practice
 
Luis A. Diaz
Leadership - Jounce Therapeutics; Personal Genome Diagnostics
Stock and Other Ownership Interests - Amgen (I); Four Paws; Jounce Therapeutics; Kinnate Biopharma; Neophore; PapGene, Inc.; Personal Genome Diagnostics; Seer; Thrive Earlier Detection Corp; Zydecom
Consulting or Advisory Role - Four Paws; Innovatus Capital Partners; Kinnate Biopharma; Merck; Neophore; Personal Genome Diagnostics; Seer; Zydecom
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - EP-2912468-B1 - Papanicolaou test for ovarian and endometrial cancers; EP-3322824-A1 - Detection of tumor-derived dna in cerebrospinal fluid; US-2005202465-A1 - Thymidylate synthase gene and metastasis; US-2010041048-A1 - Circulating Mutant DNA to Assess Tumor Dynamics; US-2013323167-A1 - Detecting and treating solid tumors through selective disruption of tumor vasculature; US-2014227271-A1 - Somatic mutations in atrx in brain cancer; US-2015252415-A1 - Arid1b and neuroblastoma; US-2015344970-A1 - Personalized Tumor Biomarkers; US-2016208340-A1 - TERT Promoter Mutations in Urothelial Neoplasia; US-2016273049-A1 - Systems and methods for analyzing nucleic acid (Inst); US-2017016075-A1 - Neoantigen analysis (Inst); US-2017267760-A1 - Checkpoint Blockade and Microsatellite Instability; US-2018086832-A1 - Hla-restricted epitopes encoded by somatically mutated genes; US-2018135044-A1 - Non-unique barcodes in a genotyping assay (Inst); US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018258490-A1 - Assaying ovarian cyst fluid; US-9976184-B2 - Mutations in pancreatic neoplasms; WO-2010118016-A2 - Digital quantification of dna methylation; WO-2012094401-A2 - Genes frequently altered in pancreatic neuroendocrine tumors; WO-2018071796-A2 - Compositions and methods for identifying functional anti-tumor t cell responses
Travel, Accommodations, Expenses - Merck
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Honoraria - Clinical Care Options; MedEd; RMEI Medical Education
Consulting or Advisory Role - Basilea; Health Advances; Natera
Research Funding - Guardant Health (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Merck